0.5400
+0.0273
+(5.32%)
At close: April 11 at 3:59:51 PM EDT
0.5200
-0.02
(-3.70%)
After hours: April 11 at 5:05:43 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
1,096
3,188
33
158.3330
Operating Expense
22,011
24,862
27,778
24,768
24,364.8850
Operating Income
-22,011
-23,766
-24,590
-24,735
-24,206.5520
Other Income Expense
879
824
3,593
1,452
1,759.7140
Pretax Income
-21,132
-22,942
-20,997
-23,283
-22,446.8380
Net Income Common Stockholders
-21,132
-22,942
-20,997
-23,679
-23,240.2800
Diluted NI Available to Com Stockholders
-21,132
-22,942
-20,997
-23,679
-23,240.2800
Basic EPS
-4.74
-5.50
-5.00
-5.50
-6.00
Diluted EPS
-4.74
-5.50
-5.00
-5.50
-6.00
Basic Average Shares
4,680.0010
4,345.2900
4,336.2280
4,203.5660
3,937.8920
Diluted Average Shares
4,680.0010
4,345.2900
4,336.2280
4,203.5660
3,937.8920
Total Operating Income as Reported
-22,011
-23,766
-24,590
-24,735
-24,206.5520
Total Expenses
22,011
24,862
27,778
24,768
24,364.8850
Net Income from Continuing & Discontinued Operation
-21,132
-22,942
-20,997
-23,283
-22,446.8380
Normalized Income
-21,616
-23,426
-24,488
-24,611
-23,520.1270
EBIT
-22,011
-23,766
-24,590
-24,735
-24,206.5520
EBITDA
-21,046
-22,825
-23,692
-23,954
-23,431.9650
Reconciled Depreciation
965
941
898
781
774.5870
Net Income from Continuing Operation Net Minority Interest
-21,132
-22,942
-20,997
-23,283
-22,446.8380
Total Unusual Items Excluding Goodwill
484
484
3,491
1,328
1,073.2890
Total Unusual Items
484
484
3,491
1,328
1,073.2890
Normalized EBITDA
-21,530
-23,309
-27,183
-25,282
-24,505.2540
12/31/2020 - 7/21/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EQ Equillium, Inc.
0.4790
+5.04%
KANT Kineta, Inc.
0.2660
0.00%
PRQR ProQR Therapeutics N.V.
1.1200
-0.88%
MTVA MetaVia Inc.
1.4500
+5.07%
SLGL Sol-Gel Technologies Ltd.
0.4300
-0.58%
CDXS Codexis, Inc.
2.3500
+4.44%
MEIP MEI Pharma, Inc.
1.8700
+1.63%
ARTL Artelo Biosciences, Inc.
0.8219
-1.33%
LIXT Lixte Biotechnology Holdings, Inc.
1.2100
+3.42%
NBY NovaBay Pharmaceuticals, Inc.
0.5299
+8.14%